Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Oesophago-gastric Cancer × Panitumumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 56 Colonic Neoplasms 17 Rectal Neoplasms 10 Esophageal Neoplasms 9 Neoplasm Metastasis 7 Pancreatic Neoplasms 6 Cholangiocarcinoma 6 Breast Neoplasms 6 Neoplasms 5 Colorectal Cancer Metastatic 5 Carcinoma, Non-Small-Cell Lung 5 Squamous Cell Carcinoma of Head and Neck 4 Head and Neck Neoplasms 4 Triple Negative Breast Neoplasms 3 Ovarian Neoplasms 3 Carcinoma, Squamous Cell 3 Adenocarcinoma Of Esophagus 3 Urinary Bladder Neoplasms 2 Stomach Neoplasms 2 Recurrence 2 Prostatic Neoplasms 2 Lung Neoplasms 2 Inflammatory Breast Neoplasms 2 Glioma 2 Gastrointestinal Neoplasms 2 Carcinoma 2 Adenocarcinoma 2 Unspecified Adult Solid Tumor, Protocol Specific 1 Solid Tumors 1 Serotonin Syndrome 1

Interventions

Panitumumab 1 Oxaliplatin 1 Epirubicin 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00824785 2012-12-11

REAL3

Royal Marsden NHS Foundation Trust

Phase 3 Terminated

Gastrointestinal

Oesophago-gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡